The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Chemogenomic approaches to rational drug design
Open accessAbstract
Paradigms in drug design and discovery are changing at a significant pace. Concomitant to the sequencing of over 180 several genomes, the high‐throughput miniaturization of chemical synthesis and biological evaluation of a multiple compounds on gene/protein expression and function opens the way to global drug‐discovery approaches, no more focused on a single target but on an entire family of related proteins or on a full metabolic pathway. Chemogenomics is this emerging research field aimed at systematically studying the biological effect of a wide array of small molecular‐weight ligands on a wide array of macromolecular targets. Since the quantity of existing data (compounds, targets and assays) and of produced information (gene/protein expression levels and binding constants) are too large for manual manipulation, information technologies play a crucial role in planning, analysing and predicting chemogenomic data. The present review will focus on predictive in silico chemogenomic approaches to foster rational drug design and derive information from the simultaneous biological evaluation of multiple compounds on multiple targets. State‐of‐the‐art methods for navigating in either ligand or target space will be presented and concrete drug design applications will be mentioned. British Journal of Pharmacology (2007) 152, 38–52; doi:10.1038/sj.bjp.0707307
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: A Priori Inference of Cross Reactivity for Drug-Targeted Kinases
Fernández, A., & Maddipati, S. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060163j · Cited by 30
RetractedBerman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Pfam: clans, web tools and services
Finn, R. D. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj149 · Cited by 2,302
Protein structure alignment by incremental combinatorial extension (CE) of the optimal path
Shindyalov, I. N., & Bourne, P. E. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.9.739 · Cited by 2,041
The Sequence of the Human Genome
Venter, J. C., Smith, H. O., & Adams, M. D. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.237016 · Cited by 1,648
Evans, B. E., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., Lundell, G. F., Veber, D. F., Anderson, P. S., Chang, R. S. L., et al. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00120a002 · Cited by 1,456
The Universal Protein Resource (UniProt): an expanding universe of protein information
Wu, C. H. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj161 · Cited by 1,110
ModBase, a database of annotated comparative protein structure models, and associated resources
Pieper, U., Webb, B. M., Barkan, D. T., Schneidman-Duhovny, D., Schlessinger, A., Braberg, H., Yang, Z., Meng, E. C., Pettersen, E. F., Huang, C. C., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1091 · Cited by 1,071
Hulo, N. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj063 · Cited by 971
DaliLite workbench for protein structure comparison
Holm, L., & Park, J. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.6.566 · Cited by 888
Similarity-based virtual screening using 2D fingerprints
Willett, P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.005 · Cited by 849 · cited 2×
“Much faster are fingerprint-based methods (Willett, 2006), where the occurrence of predefined structural events (atoms, fragments, rings, substructures and 2-D pharmacophores) are encoded into bit strings (sequence of ‘0’ and ‘1’ digits) called ‘fingerprints’ which ere easy to derive, handle and compare.”
BackgroundGlobal mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
Molecular similarity: a key technique in molecular informatics
Bender, A., & Glen, R. C. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409813g · Cited by 614
Deng, Z., Chuaqui, C., & Singh, J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030331x · Cited by 563
Koch, M. A., Schuffenhauer, A., Scheck, M., Wetzel, S., Casaulta, M., Odermatt, A., Ertl, P., & Waldmann, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503647102 · Cited by 544
Assessing Scoring Functions for Protein−Ligand Interactions
Ferrara, P., Gohlke, H., Price, D. J., Klebe, G., & Brooks, C. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030489h · Cited by 481
Weber, A., Casini, A., Heine, A., Kuhn, D., Supuran, C. T., Scozzafava, A., & Klebe, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030912m · Cited by 454
The druggable genome: an update
Russ, A. P., & Lampel, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03666-4 · Cited by 424
A New Method to Detect Related Function Among Proteins Independent of Sequence and Fold Homology
Schmitt, S., Kuhn, D., & Klebe, G. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00811-2 · Cited by 423
Why do we need so many chemical similarity search methods?
Sheridan, R. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02411-x · Cited by 412
Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes
An, J., Totrov, M., & Abagyan, R. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400159-mcp200 · Cited by 408
Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints
Marcou, G., & Rognan, D. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600342e · Cited by 408
Self-citationA Scoring Scheme for Discriminating between Drugs and Nondrugs
Sadowski, J., & Kubinyi, H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9706776 · Cited by 392
PRINTS and its automatic supplement, prePRINTS
Attwood, T. K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg030 · Cited by 388
Chen, Y. Z., & Zhi, D. G. (2001) · Proteins: Structure, Function, and Genetics · doi:10.1002/1097-0134(20010501)43:2<217::aid-prot1032>3.0.co;2-g · Cited by 353
Classification of Kinase Inhibitors Using a Bayesian Model
Xia, X., Maliski, E. G., Gallant, P., & Rogers, D. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303195 · Cited by 352
Nidhi, Glick, M., Davies, J. W., & Jenkins, J. L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060003g · Cited by 340
Wallace, A. C., Borkakoti, N., & Thornton, J. M. (1997) · Protein Science · doi:10.1002/pro.5560061104 · Cited by 329
Binding MOAD (Mother Of All Databases)
Hu, L., Benson, M. L., Smith, R. D., Lerner, M. G., & Carlson, H. A. (2005) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20512 · Cited by 328
Nussinov, R., & Wolfson, H. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10495 · Cited by 288
Recognition of Functional Sites in Protein Structures
Shulman-Peleg, A., Nussinov, R., & Wolfson, H. J. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.04.012 · Cited by 269
MODBASE: a database of annotated comparative protein structure models and associated resources
Pieper, U. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj059 · Cited by 253
Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins
Schuffenhauer, A., Floersheim, P., Acklin, P., & Jacoby, E. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci025569t · Cited by 252
A chemogenomic analysis of the transmembrane binding cavity of human G‐protein‐coupled receptors
Surgand, J., Rodrigo, J., Kellenberger, E., & Rognan, D. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20768 · Cited by 220
Self-citationArtymiuk, P. J., Poirrette, A. R., Grindley, H. M., Rice, D. W., & Willett, P. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1657 · Cited by 209
Predicting ligand binding to proteins by affinity fingerprinting
Kauvar, L. M., Higgins, D. L., Villar, H. O., Sportsman, J. R., Engqvist-Goldstein, Å., Bukar, R., Bauer, K. E., Dilley, H., & Rocke, D. M. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90283-x · Cited by 208
sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank
Kellenberger, E., Muller, P., Schalon, C., Bret, G., Foata, N., & Rognan, D. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050372x · Cited by 201
Self-citationBridging Chemical and Biological Space: “Target Fishing” Using 2D and 3D Molecular Descriptors
Nettles, J. H., Jenkins, J. L., Bender, A., Deng, Z., Davies, J. W., & Glick, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060902w · Cited by 201
Recognition of Privileged Structures by G-Protein Coupled Receptors
Bondensgaard, K., Ankersen, M., Thøgersen, H., Hansen, B. S., Wulff, B. S., & Bywater, R. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0309452 · Cited by 181
Predicting ADME properties and side effects: the BioPrint approach.
Krejsa, C. M., Horvath, D., Rogalski, S. L., Penzotti, J. E., Mao, B., Barbosa, F., & Migeon, J. (2003) · PubMed · Cited by 176
Kinomics—structural biology and chemogenomics of kinase inhibitors and targets
Vieth, M., Higgs, R. E., Robertson, D. H., Shapiro, M., Gragg, E. A., & Hemmerle, H. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.028 · Cited by 175
Chemogenomic approaches to drug discovery
Caron, P. R., Mullican, M. D., Mashal, R. D., Wilson, K. P., Su, M. S., & Murcko, M. A. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00229-5 · Cited by 165
A new bioinformatic approach to detect common 3D sites in protein structures
Jambon, M., Imberty, A., Deléage, G., & Geourjon, C. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10339 · Cited by 165
Kinoshita, K., & Nakamura, H. (2003) · Protein Science · doi:10.1110/ps.0368703 · Cited by 162
Morphy, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0512185 · Cited by 123
Structural Diversity of Domain Superfamilies in the CATH Database
Reeves, G. A., Dallman, T. J., Redfern, O., Akpor, A., & Orengo, C. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.05.035 · Cited by 115
Parallel Screening: A Novel Concept in Pharmacophore Modeling and Virtual Screening
Steindl, T. M., Schuster, D., Laggner, C., et al. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci6002043 · Cited by 111
Bender, A., Jenkins, J. L., Glick, M., Deng, Z., Nettles, J. H., & Davies, J. W. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600197y · Cited by 110
Recovering the true targets of specific ligands by virtual screening of the protein data bank
Paul, N., Kellenberger, E., Bret, G., Müller, P., & Rognan, D. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10625 · Cited by 109
Self-citationGold, N. D., & Jackson, R. M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.044 · Cited by 106
Comparison of protein active site structures for functional annotation of proteins and drug design
Powers, R., Copeland, J. C., Germer, K., Mercier, K., Ramanathan, V., & Revesz, P. Z. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21092 · Cited by 102
Are Target-Family-Privileged Substructures Truly Privileged?
Schnur, D. M., Hermsmeier, M. A., & Tebben, A. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0502900 · Cited by 101
Virtual Screen for Ligands of Orphan G Protein-Coupled Receptors
Bock, J. R., & Gough, D. A. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050006d · Cited by 100
Naumann, T., & Matter, H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011002c · Cited by 97
Chuaqui, C. E., Deng, Z., & Singh, J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049312t · Cited by 96
Biological mechanism profiling using an annotated compound library
Root, D. E., Flaherty, S. P., Kelley, B. P., & Stockwell, B. R. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.08.009 · Cited by 95
Ligand-Based Approach to In Silico Pharmacology: Nuclear Receptor Profiling
Mestres, J., Martín‐Couce, L., Gregori‐Puigjané, E., Cases, M., & Boyer, S. K. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600300k · Cited by 89
Votano, J. R., Parham, M., Hall, L. H., Kier, L. B., & Hall, L. M. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490137 · Cited by 74
Singh, J., Deng, Z., Narale, G., & Chuaqui, C. E. (2005) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00323.x · Cited by 72
Müller, P., Léna, G., Boilard, É., Bezzine, S., Lambeau, G. J., Guichard, G., & Rognan, D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0606589 · Cited by 70
Self-citationA physicogenetic method to assign ligand-binding relationships between 7TM receptors
Frimurer, T. M., Ulven, T., Elling, C., Gerlach, L., Kostenis, E., & Högberg, T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.102 · Cited by 66
Knowledge-Based Design of Target-Focused Libraries Using Protein−Ligand Interaction Constraints
Deng, Z., Chuaqui, C. E., & Singh, J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050381x · Cited by 63
Pirard, B., & Matter, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050363f · Cited by 59
Kratochwil, N. A., Malherbe, P., Lindemann, L., Ebeling, M., Hoener, M. C., Mühlemann, A., Porter, R. H. P., Ståhl, M., & Gerber, P. R. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050221u · Cited by 59
Generalized Fragment-Substructure Based Property Prediction Method
Clark, M. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049744c · Cited by 56
Matter, H., & Schwab, W. G. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990250u · Cited by 53
Similarity networks of protein binding sites
Zhang, Z., & Grigorov, M. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20752 · Cited by 50
Oloff, S., Zhang, S., Sukumar, N., Breneman, C. M., & Tropsha, A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050065r · Cited by 48
Inhibitor design by wrapping packing defects in HIV-1 proteins
Fernández, A., Rogale, K., Scott, R., & Scheraga, H. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404641101 · Cited by 31
Domain-based small molecule binding site annotation
Snyder, K. A., Feldman, H. J., Dumontier, M., Salama, J. J., & Hogue, C. W. V. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-152 · Cited by 27
Incomplete Protein Packing as a Selectivity Filter in Drug Design
Fernández, A. (2005) · Structure · doi:10.1016/j.str.2005.08.018 · Cited by 23
Hoppe, C., Steinbeck, C., & Wohlfahrt, G. (2005) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2005.09.013 · Cited by 21
(2002) · doi:10.1002/1439-7633(20021004)3:10<928::aid-cbic928>3.0.co;2-5
Cited by
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Liu, X., Ouyang, S., Yu, B., Liu, Y., Huang, K., Gong, J., Zheng, S., Li, Z., Li, H., & Jiang, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq300 · Cited by 967
Virtual Screening Strategies in Drug Discovery: A Critical Review
Lavecchia, A., & Giovanni, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990001 · Cited by 686
Rifaioglu, A. S., Atas, H., Martin, M. J., Cetin-Atalay, R., Atalay, V., & Doğan, T. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby061 · Cited by 529
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Metadata
- Authors
- Rognan, D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-09
- Volume
- 152
- Issue
- 1
- Pages
- 38-52
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2137507165
- Cited by
- 269
- References
- 79
- FWCI
- 28.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.